Defence Therapeutics Inc. (CSE:DTC)
Canada · Delayed Price · Currency is CAD 0.3500
0.00 (0.00%)
Oct 30, 2026, 3:57 PM EDT
Defence Therapeutics Balance Sheet
Financials in millions CAD. Fiscal year is July - June.
Millions CAD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 1.88 | 1.23 | 0.06 | 2.79 | 0.51 |
Cash & Short-Term Investments | 1.88 | 1.23 | 0.06 | 2.79 | 0.51 |
Cash Growth | 52.40% | 2079.47% | -97.97% | 451.20% | -90.71% |
Other Receivables | 2.44 | 0.2 | 0.1 | 0.15 | 0.03 |
Receivables | 2.44 | 0.2 | 0.1 | 0.15 | 0.03 |
Prepaid Expenses | 0.06 | 0.03 | 0.06 | 0.49 | 0.14 |
Total Current Assets | 4.38 | 1.46 | 0.21 | 3.43 | 0.67 |
Property, Plant & Equipment | 0.68 | 0.19 | 0.26 | 0.06 | - |
Other Intangible Assets | - | - | - | 0.04 | 0.05 |
Other Long-Term Assets | 1.45 | - | - | - | - |
Total Assets | 6.51 | 1.65 | 0.48 | 3.53 | 0.72 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 1.28 | 1.33 | 2.09 | 0.19 | 0.98 |
Short-Term Debt | - | - | 0.05 | - | - |
Current Portion of Long-Term Debt | - | 1.49 | 1.66 | - | - |
Current Portion of Leases | - | 0.02 | 0.03 | - | - |
Other Current Liabilities | - | 0.07 | 0.22 | 0.03 | 0.13 |
Total Current Liabilities | 1.28 | 2.91 | 4.05 | 0.22 | 1.11 |
Long-Term Debt | 1.72 | - | - | 1.75 | - |
Long-Term Leases | - | - | 0.01 | - | - |
Total Liabilities | 3 | 2.91 | 4.06 | 1.97 | 1.11 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 34.72 | 24.19 | 19.24 | 16.95 | 9.33 |
Retained Earnings | -35.78 | -29.31 | -29.81 | -16.91 | -10.52 |
Comprehensive Income & Other | 4.57 | 3.86 | 6.98 | 1.52 | 0.79 |
Shareholders' Equity | 3.51 | -1.26 | -3.58 | 1.57 | -0.39 |
Total Liabilities & Equity | 6.51 | 1.65 | 0.48 | 3.53 | 0.72 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 1.72 | 1.5 | 1.75 | 1.75 | - |
Net Cash (Debt) | 0.16 | -0.27 | -1.69 | 1.05 | 0.51 |
Net Cash Growth | - | - | - | 106.61% | -90.71% |
Net Cash Per Share | 0.00 | -0.01 | -0.04 | 0.03 | 0.01 |
Filing Date Shares Outstanding | 75.67 | 54.73 | 45.54 | 44.27 | 37.68 |
Total Common Shares Outstanding | 75.67 | 54.73 | 45.54 | 43.78 | 36.63 |
Working Capital | 3.1 | -1.44 | -3.84 | 3.21 | -0.43 |
Book Value Per Share | 0.05 | -0.02 | -0.08 | 0.04 | -0.01 |
Tangible Book Value | 3.51 | -1.26 | -3.58 | 1.53 | -0.43 |
Tangible Book Value Per Share | 0.05 | -0.02 | -0.08 | 0.03 | -0.01 |
Machinery | - | 0.27 | 0.27 | 0.07 | - |